China Pharma Holdings's market cap is currently ―. The company's EPS TTM is $-1.003; its P/E ratio is -0.32; China Pharma Holdings is scheduled to report earnings on May 16, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.80M	$ 1.10M	$ 1.96M	$ 2.92M	$ 1.97M
Gross Profit	$ -233.19K	$ -146.66K	$ 177.92K	$ 42.68K	$ -137.76K
EBIT	$ -711.36K	$ -455.37K	$ -396.53K	$ -1.17M	$ -686.80K
EBITDA	$ -52.52K	$ 263.74K	$ 283.35K	$ -529.59K	$ -22.46K
Net Income Common Stockholders	$ -777.60K	$ -593.03K	$ 4.24M	$ -1.26M	$ -790.77K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.37M	$ 901.91K	$ 1.17M	$ 2.03M	$ 2.09M
Total Assets	$ 15.35M	$ 15.70M	$ 17.36M	$ 17.78M	$ 16.20M
Total Debt	$ 4.28M	$ 5.34M	$ 6.15M	$ 6.28M	$ 10.11M
Net Debt	$ 2.91M	$ 4.44M	$ 4.99M	$ 4.25M	$ 8.03M
Total Liabilities	$ 9.24M	$ 11.35M	$ 12.69M	$ 13.49M	$ 13.37M
Stockholders Equity	$ 6.11M	$ 4.35M	$ 4.67M	$ 4.29M	$ 2.83M
Cash Flow	-
Free Cash Flow	$ 1.00M	$ -216.44K	$ -1.47M	$ 611.86K	$ -33.43K
Operating Cash Flow	$ 1.01M	$ -216.44K	$ -1.47M	$ 584.59K	$ 219.12K
Investing Cash Flow	$ -67.45K	$ 4.50K	$ 55.96K	$ 27.27K	$ -252.55K
Financing Cash Flow	$ -476.40K	$ 934.00	$ 518.24K	$ -672.06K	$ 28.39K

Currency in USD

China Pharma Holdings Earnings and Revenue History

Income Statement >

China Pharma Holdings Debt to Assets

Balance Sheet >

China Pharma Holdings Cash Flow

Cash Flow >

China Pharma Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing